Virus and Bronchial Epithelium in Children and the Elderly

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

April 28, 2025

Study Completion Date

April 28, 2025

Conditions
SARS-CoV-2
Interventions
BIOLOGICAL

SARS-CoV-2

Circulating strains of SARS-CoV-2 (including variants of concern) were already collected, cultured and purified. The Wuhan reference strain will be used in the VIRCHILLD study to infect cells.

BIOLOGICAL

Adenovirus (AdV)

Infection with C-type viruses (e.g. HAd-C5) using bronchial epithelium from adult donors

BIOLOGICAL

Rhinovirus

RV is a member of the picornaviridae family; small non-enveloped viruses with a single strand positive RNA genome protected by an icosahedral capsid. They are divided in more than 160 serotypes classed in subtype A, B and C. RV-A and RV-C infections will be used in the VIRCHILLD study

BIOLOGICAL

No Intervention

no infection

Trial Locations (1)

33076

RECRUITING

Bordeaux University Hospital, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER